Cypress Capital Management (Delaware)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,540	Closed	-$239K	–	159
2018 Q4	$239K	Hold	6,540	–	–	0.05%	137
2018 Q3	$318K	Sell	6,540 -100	-2%	-$4.74K	0.06%	128
2018 Q2	$286K	Hold	6,640	–	–	0.05%	127
2018 Q1	$278K	Sell	6,640 -280	-4%	-$12.2K	0.05%	123
2017 Q4	$301K	Hold	6,920	–	–	0.06%	121
2017 Q3	$294K	Sell	6,920 -350	-5%	-$14.8K	0.06%	111
2017 Q2	$313K	Sell	7,270 -1,450	-17%	-$61.1K	0.07%	97
2017 Q1	$365K	Sell	8,720 -360	-4%	-$14.7K	0.09%	83
2016 Q4	$355K	Sell	9,080 -46,215	-84%	-$1.88M	0.09%	79
2016 Q3	$2.44M	Sell	55,295 -2,290	-4%	-$104K	0.78%	36
2016 Q2	$2.41M	Sell	57,585 -2,580	-4%	-$109K	0.81%	37
2016 Q1	$2.42M	Sell	60,165 -810	-1%	-$34.3K	0.82%	39
2015 Q4	$3.12M	Buy	60,975 +25,535	+72%	+$1.3M	0.93%	39
2015 Q3	$1.66M	Buy	35,440 +22,000	+164%	+$1.33M	0.53%	42
2015 Q2	$838K	Buy	13,440 +1,600	+14%	+$99.7K	0.24%	46
2015 Q1	$731K	Buy	11,840 +340	+3%	+$20.2K	0.22%	45
2014 Q4	$621K	Buy	11,500 +2,820	+32%	+$154K	0.18%	45
2014 Q3	$460K	Buy	8,680 +2,760	+47%	+$140K	0.14%	40
2014 Q2	$307K	Buy	+5,920	New	+$286K	0.09%	44

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Cypress Capital Management (Delaware)'s XPH Position: Q1 2019 in Review

Cypress Capital Management (Delaware) sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2019, closing a stake of 6,540 shares — an estimated $239K sold.

Cypress Capital Management (Delaware) first reported a position in XPH in Q2 2014 and held it in 19 quarters. The position peaked at $3.12M in Q4 2015. 80 funds tracked by Wall St. Rank hold XPH as of Q1 2019.

Cypress Capital Management (Delaware) reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
Cypress Capital Management (Delaware) sold 6,540 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2019, an estimated $239K.
Cypress Capital Management (Delaware) first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2014 and held it in 19 quarters.
Cypress Capital Management (Delaware)'s State Street SPDR S&P Pharmaceuticals ETF position peaked at $3.12M in Q4 2015.
80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2019.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q1 2019, filed 6 May 2019.